Opus Genetics, Inc.

IRD · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$17-$7-$8-$35
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$1$1
Change in WC$1-$3-$0$1
Other Non-Cash$10-$0-$1$25
Operating Cash Flow-$6-$10-$9-$7
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$1
Investing Cash Flow$0$0$0$1
Financing Activities
Debt Repay.$0$1$0$0
Stock Issued$5-$0$6$0
Stock Repurch.$0$0-$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$14-$0
Financing Cash Flow$5$1$20-$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$9$11-$6
Supplemental Information
Beg. Cash$32$42$30$37
End Cash$31$32$42$30
Free Cash Flow-$6-$10-$9-$7
Opus Genetics, Inc. (IRD) Financial Statements & Key Stats | AlphaPilot